These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935). Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138 [TBL] [Abstract][Full Text] [Related]
8. [Fibrinolysis with rt-PA in peripheral arterial occlusions]. Hess H; Mietaschk A; Becker-Lienau C Klin Wochenschr; 1988; 66 Suppl 12():135-6. PubMed ID: 3126341 [TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator. Berridge DC; Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR Thromb Haemost; 1989 Apr; 61(2):275-8. PubMed ID: 2501898 [TBL] [Abstract][Full Text] [Related]
10. [Local intra-arterial thrombolysis in acute ischemia of an extremity]. Enevoldsen MT; Rørdam P; Schroeder TV Ugeskr Laeger; 1996 Sep; 158(36):5011-4. PubMed ID: 8928238 [TBL] [Abstract][Full Text] [Related]
11. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators. Sabovic M; Lijnen HR; Keber D; Collen D Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603 [TBL] [Abstract][Full Text] [Related]
12. [Local low dosage thrombolysis with rt-PA. Systemic effects on the fibrinolytic system--data on the assessment of the value and risk of this method]. von Bilderling P; Spannagl M; Mietaschk A; Iven M; Schramm W; Hess H Vasa Suppl; 1991; 33():132-3. PubMed ID: 1788645 [TBL] [Abstract][Full Text] [Related]
13. [Thrombotic and thromboembolic occlusions of leg arteries and bypasses. Short-term versus long-term lysis]. Zwaan M; Rinast E; Kummer-Kloess D; Weiss HD; Gmelin E Rofo; 1993 Jun; 158(6):536-41. PubMed ID: 8507844 [TBL] [Abstract][Full Text] [Related]
14. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro. Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224 [TBL] [Abstract][Full Text] [Related]
15. Thrombolytic treatment of acute pulmonary embolism. Charbonnier B; Meyer G; Stern M; Sors H; Brochier ML Herz; 1989 Jun; 14(3):157-71. PubMed ID: 2500388 [TBL] [Abstract][Full Text] [Related]
16. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery. Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462 [TBL] [Abstract][Full Text] [Related]
17. A study of the use of the thromboxane A2 antagonist, sulotroban, in combination with streptokinase for local thrombolysis in patients with recent peripheral arterial occlusions: clinical effects, platelet function and fibrinolytic parameters. Lonsdale RJ; Heptinstall S; Westby JC; Berridge DC; Wenham PW; Hopkinson BR; Makin GS Thromb Haemost; 1993 Feb; 69(2):103-11, 123. PubMed ID: 8456421 [TBL] [Abstract][Full Text] [Related]
18. Thrombolytic therapy for arterial occlusion: a mixed blessing. Smith CM; Yellin AE; Weaver FA; Li KM; Siegel AE Am Surg; 1994 May; 60(5):371-5. PubMed ID: 8161090 [TBL] [Abstract][Full Text] [Related]
19. [New thrombolytic agents in myocardial infarction]. Charbonnier B; Lang M; Brochier M Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222 [TBL] [Abstract][Full Text] [Related]